A decerebrating female: A rare presentation of acute disseminated encephalomyelitis due to
measles.
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Few cases of acute disseminated encephalomyelitis (ADEM) secondary to Rubeola have been
reported since the discovery of the Measles, Mumps, Rubella (MMR) vaccine in 1968. ADEM is
a rare, rapidly progressive, immune-mediated demyelinating disorder of the central nervous
system that usually presents in pediatric populations following routine vaccination or infection.
Typically presenting with polymorphous neurological symptoms, ADEM is primarily a diagnosis
of exclusion. Magnetic resonance imaging (MRI), however, is usually necessary for diagnosis.
Multiple therapeutic options have been proposed, but no treatment guidelines are currently
available.
A 70 year-old unvaccinated immigrant female with no past medical history presented to our
hospital with right flank pain, dysuria and fevers. She reported recent travel to Brazil and
exposure to a 7-month-old infant with fevers and rash. On exam, a right cranial nerve VI palsy
was present. On admission, brain computed tomography was unremarkable; brain MRI reported
multifocal diffusion restriction and abnormal T2-weighted Fluid Attenuated Inversion Recovery
hyperintense signal in the brainstem, bilateral thalami, cerebral hemispheres and cerebellum.
Initial cerebrospinal fluid (CSF) analysis was nonspecific. By day 3 she progressed to
decerebrate posture, became unresponsive and required endotracheal intubation. Pulse-dose
steroids were given for 5 days with no improvement. On day 8 she underwent brain biopsy;
pathology was unremarkable. Intravenous Immune globulin (IVIG) was initiated followed by
cyclophosphamide. Ultimately, CSF analysis yielded elevated IgM for Rubeola, followed by
serology positive for Rubeola IgM, establishing the diagnosis. After initiating plasmapheresis,
her neurologic status improved dramatically.
As of July of 2019, since its eradication in 2000, the incidence of measles reported in the United
States is at its highest. Currently, the frequency of ADEM secondary to measles in the adult
population is unreported. With the novel rise of the anti-vaccine movement, measles must be in
the differential diagnosis of patients presenting unexplained neurologic deficits. Although
evidence is lacking for the most effective therapy, prompt treatment for ADEM may mitigate
long-term neurologic sequelae.
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